Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-01-27

FDA Approved: NEBIVOLOL — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Nebivolol filed by ANI Pharmaceuticals, Inc. for Nebivolol product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)

Snippet

SUPPL AP for NEBIVOLOL (NEBIVOLOL)